| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
The FASEB Journal, Vol 11, 181-188, Copyright © 1997 by The Federation of American Societies for Experimental Biology
RESEARCH COMMUNICATIONS |
SE Spycher, S Tabataba-Vakili, VB O'Donnell, L Palomba and A Azzi
Institut fur Biochemie und Molekularbiologie, Universitat Bern, Switzerland.
Hydrogen peroxide (H2O2) or 4-hydroxy-2,3-trans-nonenal (HNE) treatment of rat vascular smooth muscle cells (A7r5) caused induction of aldose reductase mRNA. Induction was dose (10-100 microM H2O2, 1-10 microM HNE) and time dependent, reaching a maximum (three- to fourfold) after 7-12 h. Treatment of cells with actinomycin D confirmed de novo synthesis of aldose reductase mRNA. H2O2-induced expression was prevented by catalase but unaffected by Desferal, indicating that metal catalyzed degradation of peroxide was not involved. Induction of enzymatically active aldose reductase by H2O2 and HNE was confirmed using Western blotting and enzyme assays. Aldose reductase can metabolize several aldehyde compounds including HNE, a major toxic product of lipid peroxidation. Inclusion of Sorbinil, an aldose reductase inhibitor, in toxicity assays resulted in a significant (twofold) enhancement of HNE-mediated killing of A7r5 cells, suggesting a protective role of aldose reductase against HNE-induced cell death. These data indicate that the induction of aldose reductase during oxidative stress might represent an important cellular antioxidant defense mechanism.
This article has been cited by other articles:
|
|
 |
|
  C. A. Gleissner, J. M. Sanders, J. Nadler, and K. Ley Upregulation of Aldose Reductase During Foam Cell Formation as Possible Link Among Diabetes, Hyperlipidemia, and Atherosclerosis Arterioscler. Thromb. Vasc. Biol., June 1, 2008; 28(6): 1137 - 1143. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Kaiserova, X.-L. Tang, S. Srivastava, and A. Bhatnagar Role of Nitric Oxide in Regulating Aldose Reductase Activation in the Ischemic Heart J. Biol. Chem., April 4, 2008; 283(14): 9101 - 9112. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. B. Burg, J. D. Ferraris, and N. I. Dmitrieva Cellular Response to Hyperosmotic Stresses Physiol Rev, October 1, 2007; 87(4): 1441 - 1474. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Kaiserova, S. Srivastava, J. D. Hoetker, S. O. Awe, X.-L. Tang, J. Cai, and A. Bhatnagar Redox Activation of Aldose Reductase in the Ischemic Heart J. Biol. Chem., June 2, 2006; 281(22): 15110 - 15120. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Wojnowski, B. Kulle, M. Schirmer, G. Schluter, A. Schmidt, A. Rosenberger, S. Vonhof, H. Bickeboller, M. R. Toliat, E.-K. Suk, et al. NAD(P)H Oxidase and Multidrug Resistance Protein Genetic Polymorphisms Are Associated With Doxorubicin-Induced Cardiotoxicity Circulation, December 13, 2005; 112(24): 3754 - 3762. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Aragno, R. Mastrocola, C. Medana, F. Restivo, M. G. Catalano, N. Pons, O. Danni, and G. Boccuzzi Up-Regulation of Advanced Glycated Products Receptors in the Brain of Diabetic Rats Is Prevented by Antioxidant Treatment Endocrinology, December 1, 2005; 146(12): 5561 - 5567. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. K. Srivastava, K. V. Ramana, and A. Bhatnagar Role of Aldose Reductase and Oxidative Damage in Diabetes and the Consequent Potential for Therapeutic Options Endocr. Rev., May 1, 2005; 26(3): 380 - 392. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. R. Danielson, V. Carelli, G. Tan, A. Martinuzzi, A. H. V. Schapira, M.-L. Savontaus, and G. A. Cortopassi Isolation of transcriptomal changes attributable to LHON mutations and the cybridization process Brain, May 1, 2005; 128(5): 1026 - 1037. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Srivastava, M. Spite, J. O. Trent, M. B. West, Y. Ahmed, and A. Bhatnagar Aldose Reductase-catalyzed Reduction of Aldehyde Phospholipids J. Biol. Chem., December 17, 2004; 279(51): 53395 - 53406. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. V. RAMANA, A. BHATNAGAR, and S. K. SRIVASTAVA Inhibition of aldose reductase attenuates TNF-{alpha}-induced expression of adhesion molecules in endothelial cells FASEB J, August 1, 2004; 18(11): 1209 - 1218. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Minotti, P. Menna, E. Salvatorelli, G. Cairo, and L. Gianni Anthracyclines: Molecular Advances and Pharmacologic Developments in Antitumor Activity and Cardiotoxicity Pharmacol. Rev., June 1, 2004; 56(2): 185 - 229. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Corna, P. Santambrogio, G. Minotti, and G. Cairo Doxorubicin Paradoxically Protects Cardiomyocytes against Iron-mediated Toxicity: ROLE OF REACTIVE OXYGEN SPECIES AND FERRITIN J. Biol. Chem., April 2, 2004; 279(14): 13738 - 13745. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. A. DICKINSON and H. J. FORMAN Glutathione in Defense and Signaling: Lessons from a Small Thiol Ann. N.Y. Acad. Sci., November 1, 2002; 973(1): 488 - 504. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Chandra, E. B. Jackson, K. V. Ramana, R. Kelley, S. K. Srivastava, and A. Bhatnagar Nitric Oxide Prevents Aldose Reductase Activation and Sorbitol Accumulation During Diabetes Diabetes, October 1, 2002; 51(10): 3095 - 3101. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. V. Ramana, D. Chandra, S. Srivastava, A. Bhatnagar, B. B. Aggarwal, and S. K. Srivastava Aldose Reductase Mediates Mitogenic Signaling in Vascular Smooth Muscle Cells J. Biol. Chem., August 23, 2002; 277(35): 32063 - 32070. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Shinmura, R. Bolli, S.-Q. Liu, X.-L. Tang, E. Kodani, Y.-t. Xuan, S. Srivastava, and A. Bhatnagar Aldose Reductase Is an Obligatory Mediator of the Late Phase of Ischemic Preconditioning Circ. Res., August 9, 2002; 91(3): 240 - 246. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. C. Chang, K. S. Paek, H. J. Kim, Y. S. Lee, C. Yabe-Nishimura, and H. G. Seo Substrate-Induced Up-Regulation of Aldose Reductase by Methylglyoxal, a Reactive Oxoaldehyde Elevated in Diabetes Mol. Pharmacol., May 1, 2002; 61(5): 1184 - 1191. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Ruef, S.-Q. Liu, C. Bode, M. Tocchi, S. Srivastava, M. S. Runge, and A. Bhatnagar Involvement of Aldose Reductase in Vascular Smooth Muscle Cell Growth and Lesion Formation After Arterial Injury Arterioscler. Thromb. Vasc. Biol., July 1, 2000; 20(7): 1745 - 1752. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. G. Seo, T. Nishinaka, and C. Yabe-Nishimura Nitric Oxide Up-Regulates Aldose Reductase Expression in Rat Vascular Smooth Muscle Cells: A Potential Role for Aldose Reductase in Vascular Remodeling Mol. Pharmacol., April 1, 2000; 57(4): 709 - 717. [Abstract] [Full Text]
|
|
|
|
 |
|
 T. Thomas, F. Rauscher, R. Sanders, J. Veltman, and J. B. Watkins III Effects of Aldose Reductase Inhibitors on Antioxidant Defense in Rat and Rabbit Liver Toxicol. Sci., January 1, 2000; 53(1): 145 - 149. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. E. Burczynski, H.-K. Lin, and T. M. Penning Isoform-specific Induction of a Human Aldo-Keto Reductase by Polycyclic Aromatic Hydrocarbons (PAHs), Electrophiles, and Oxidative Stress: Implications for the Alternative Pathway of PAH Activation Catalyzed by Human Dihydrodiol Dehydrogenase Cancer Res., February 1, 1999; 59(3): 607 - 614. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. MINOTTI, G. CAIRO, and E. MONTI Role of iron in anthracycline cardiotoxicity: new tunes for an old song? FASEB J, February 1, 1999; 13(2): 199 - 212. [Abstract] [Full Text]
|
|
|
|
 |
|
 R.-M. Liu, L. Gao, J. Choi, and H. J. Forman gamma -Glutamylcysteine synthetase: mRNA stabilization and independent subunit transcription by 4-hydroxy-2-nonenal Am J Physiol Lung Cell Mol Physiol, November 1, 1998; 275(5): L861 - L869. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Godon, G. Lagniel, J. Lee, J.-M. Buhler, S. Kieffer, M. Perrot, H. Boucherie, M. B. Toledano, and J. Labarre The H2O2 Stimulon in Saccharomyces cerevisiae J. Biol. Chem., August 28, 1998; 273(35): 22480 - 22489. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Srivastava, A. Chandra, L.-F. Wang, W. E. Seifert Jr., B. B. DaGue, N. H. Ansari, S. K. Srivastava, and A. Bhatnagar Metabolism of the Lipid Peroxidation Product, 4-Hydroxy-trans-2-nonenal, in Isolated Perfused Rat Heart J. Biol. Chem., May 1, 1998; 273(18): 10893 - 10900. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 X. Wang and G. Z Feuerstein The use of mRNA differential display for discovery of novel therapeutic targets in cardiovascular disease Cardiovasc Res, September 1, 1997; 35(3): 414 - 421. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. E. Burczynski, G. R. Sridhar, N. T. Palackal, and T. M. Penning The Reactive Oxygen Species- and Michael Acceptor-inducible Human Aldo-Keto Reductase AKR1C1 Reduces the alpha ,beta -Unsaturated Aldehyde 4-Hydroxy-2-nonenal to 1,4-Dihydroxy-2-nonene J. Biol. Chem., January 19, 2001; 276(4): 2890 - 2897. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
